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Aim: The aim of study is to compare the 4 years clinical outcome of stent implantation with bare metal stent (BMS), first generation (sirolimus-
eluting and paclitaxel eluting stent: 1st DES) and second generation (Xience V and Nobori: 2nd DES) drug-eluting stent implantation in chronic renal 
failure with dialysis (CRF-HD).
Methods: A prospective analysis of 898 CRF-HD patients with CAD (288 BMS, 311 1st DES and 299 2nd DES) in five high volume Asian centers 
after successful stenting was performed. The study endpoints were all cause of death and major adverse cardiac events (MACE: death, MI, CABG, CV 
event and re-PCI) at 4 years.
Results: The baseline clinical characteristics between 3 groups were similar. See figures for clinical results.
Conclusion: The use of 2nd generation drug-eluting stents in patient with CRF-HD was significantly lesser incidence of MACE than that of BMS at 4 
years. 
